Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Molecular Cancer Therapeutics|October 17, 2007
Response to trastuzumab, erlotinib, and bevacizumab, alone and in combination, is correlated with the level of human epidermal growth factor receptor-2 expression in human breast cancer cell linesDavid R Emlet, Kathryn A Brown, Deborah L Kociban, et al.Cancer Research|June 15, 1989
Model for the genetic evolution of human solid tumorsS E Shackney, C A Smith, B W Miller, et al.The Journal of Thoracic and Cardiovascular Surgery|July 29, 1999
Genetic evolutionary staging of early non-small cell lung cancer: the P53 --> HER-2/NEU --> ras sequenceS E Shackney, C A Smith, A Pollice, et al.Cytometry|September 1, 1995
Preferred genetic evolutionary sequences in human breast cancer: a case studyS E Shackney, C A Smith, A A Pollice, et al.Cancer Research|June 15, 1989
Karyotypic evolution of a human undifferentiated large cell carcinoma of the lung in tissue cultureD R Burholt, S E Shackney, D M Ketterer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patientsS E Shackney, A A Pollice, C A Smith, et al.Cytometry|January 11, 1992
Sequential paraformaldehyde and methanol fixation for simultaneous flow cytometric analysis of DNA, cell surface proteins, and intracellular proteinsA A Pollice, J P McCoy, S E Shackney, et al.Cytometry|September 1, 1995
Assessing sequential oncogene amplification in human breast cancerL E Janocko, J F Lucke, D W Groft, et al.Human Molecular Genetics|October 21, 2019
Curcumin dietary supplementation ameliorates disease phenotype in an animal model of Huntington's diseaseF Elifani, E Amico, G Pepe, et al.Cytometry|July 13, 2001
Distinctive patterns of Her-2/neu, c-myc, and cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancersL E Janocko, K A Brown, C A Smith, et al.Pageof 6